Dynamic contrast-enhanced MRI in patients with muscle-invasive transitional cell carcinoma of the bladder can distinguish between residual tumour and post-chemotherapy effect.
Authors
Donaldson, Stephanie BBonington, Suzanne C
Kershaw, Lucy E
Cowan, Richard A
Lyons, Jeanette
Elliott, Tony
Carrington, Bernadette M
Affiliation
School of Cancer and Enabling Sciences, University of Manchester, Oxford Road, Manchester M13 9PL, UK; Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Wilmslow Road, Manchester M20 4BX, UK.Issue Date
2013-08-15
Metadata
Show full item recordAbstract
Treatment of muscle-invasive bladder cancer with chemotherapy results in haemorrhagic inflammation, mimicking residual tumour on conventional MR images and making interpretation difficult. The aim of this study was to use dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) to estimate descriptive and tracer kinetic parameters post-neoadjuvant chemotherapy and to investigate whether parameters differed in areas of residual tumour and chemotherapy-induced haemorrhagic inflammation (treatment effect, Tr-Eff).Citation
Dynamic contrast-enhanced MRI in patients with muscle-invasive transitional cell carcinoma of the bladder can distinguish between residual tumour and post-chemotherapy effect. 2013: Eur J RadiolJournal
European Journal of RadiologyDOI
10.1016/j.ejrad.2013.08.008PubMed ID
24034835Type
ArticleLanguage
enISSN
1872-7727ae974a485f413a2113503eed53cd6c53
10.1016/j.ejrad.2013.08.008
Scopus Count
Collections
Related articles
- Dynamic contrast enhanced MRI-derived parameters are potential biomarkers of therapeutic response in bladder carcinoma.
- Authors: Chakiba C, Cornelis F, Descat E, Gross-Goupil M, Sargos P, Roubaud G, Houédé N
- Issue date: 2015 Jun
- Evaluation of chemotherapy with magnetic resonance imaging in patients with regionally metastatic or unresectable bladder cancer.
- Authors: Schrier BP, Peters M, Barentsz JO, Witjes JA
- Issue date: 2006 Apr
- Pathological response to neoadjuvant chemotherapy for muscle-invasive micropapillary bladder cancer.
- Authors: Meeks JJ, Taylor JM, Matsushita K, Herr HW, Donat SM, Bochner BH, Dalbagni G
- Issue date: 2013 Jun
- Pathologic response in patients receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer: Is therapeutic effect owing to chemotherapy or TURBT?
- Authors: Brant A, Kates M, Chappidi MR, Patel HD, Sopko NA, Netto GJ, Baras AS, Hahn NM, Pierorazio PM, Bivalacqua TJ
- Issue date: 2017 Jan